Works by Moriwaki, Hisataka


Results: 253
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R- CHOP regimen.

    Published in:
    European Journal of Haematology, 2013, v. 91, n. 4, p. 322, doi. 10.1111/ejh.12139
    By:
    • Nakamura, Nobuhiko;
    • Goto, Naoe;
    • Tsurumi, Hisashi;
    • Takemura, Masao;
    • Kanemura, Nobuhiro;
    • Kasahara, Senji;
    • Hara, Takeshi;
    • Yasuda, Ichiro;
    • Shimizu, Masahito;
    • Sawada, Michio;
    • Yamada, Toshiki;
    • Seishima, Mitsuru;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    10

    Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens.

    Published in:
    European Journal of Haematology, 2011, v. 87, n. 3, p. 217, doi. 10.1111/j.1600-0609.2011.01649.x
    By:
    • Goto, Naoe;
    • Tsurumi, Hisashi;
    • Kasahara, Senji;
    • Kanemura, Nobuhiro;
    • Hara, Takeshi;
    • Yasuda, Ichiro;
    • Shimizu, Masahito;
    • Murakami, Nobuo;
    • Sawada, Michio;
    • Yamada, Toshiki;
    • Takemura, Masao;
    • Seishima, Mitsuru;
    • Kito, Yusuke;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    11
    12

    Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.

    Published in:
    European Journal of Haematology, 2006, v. 77, n. 3, p. 217, doi. 10.1111/j.1600-0609.2006.00702.x
    By:
    • Goto, Naoe;
    • Tsurumi, Hisashi;
    • Takemura, Masao;
    • Hara, Takeshi;
    • Sawada, Michio;
    • Kasahara, Senji;
    • Kanemura, Nobuhiro;
    • Yamada, Toshiki;
    • Shimizu, Masahito;
    • Takahashi, Takeshi;
    • Tomita, Eiichi;
    • Seishima, Mitsuru;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    13

    Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.

    Published in:
    European Journal of Haematology, 2006, v. 76, n. 6, p. 465, doi. 10.1111/j.1600-0609.2006.00631.x
    By:
    • Kojima, Yasushi;
    • Tsurumi, Hisashi;
    • Goto, Naoe;
    • Shimizu, Masahito;
    • Kasahara, Senji;
    • Yamada, Toshiki;
    • Kanemura, Nobuhiro;
    • Hara, Takeshi;
    • Sawada, Michio;
    • Saio, Masanao;
    • Yamada, Tetsuya;
    • Takahashi, Takeshi;
    • Tomita, Eiichi;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    14
    15
    16

    A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.

    Published in:
    European Journal of Haematology, 2002, v. 68, n. 6, p. 354, doi. 10.1034/j.1600-0609.2002.01654.x
    By:
    • Sawada, Michio;
    • Tsurumi, Hisashi;
    • Yamada, Toshiki;
    • Hara, Takeshi;
    • Fukuno, Kenji;
    • Goto, Hideko;
    • Shimizu, Masahito;
    • Kasahara, Senji;
    • Yoshikawa, Takeshi;
    • Kanemura, Nobuhiro;
    • Oyama, Masami;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    17

    Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.

    Published in:
    International Journal of Hematology, 2015, v. 102, n. 3, p. 327, doi. 10.1007/s12185-015-1835-8
    By:
    • Nakamura, Nobuhiko;
    • Hara, Takeshi;
    • Shimizu, Masahito;
    • Mabuchi, Ryoko;
    • Nagano, Junji;
    • Ohno, Tomohiko;
    • Kochi, Takahiro;
    • Kubota, Masaya;
    • Shirakami, Yohei;
    • Goto, Naoe;
    • Ito, Hiroyasu;
    • Saito, Kuniaki;
    • Tanaka, Takuji;
    • Moriwaki, Hisataka;
    • Tsurumi, Hisashi
    Publication type:
    Article
    18

    Clinical significance of jejunoileal involvement of non-Hodgkin's lymphoma detected by double-balloon enteroscopy.

    Published in:
    International Journal of Hematology, 2013, v. 97, n. 3, p. 369, doi. 10.1007/s12185-013-1273-4
    By:
    • Ibuka, Takashi;
    • Tsurumi, Hisashi;
    • Araki, Hiroshi;
    • Hara, Takeshi;
    • Onogi, Fumito;
    • Goto, Naoe;
    • Kojima, Yasushi;
    • Kanemura, Nobuhiro;
    • Shiraki, Makoto;
    • Kasahara, Senji;
    • Shimizu, Masahito;
    • Ogawa, Kengo;
    • Ninomiya, Soranobu;
    • Nakanishi, Takayuki;
    • Kato, Tomohiro;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy for Diagnosis of Lymphoproliferative Disorders: Feasibility of Immunohistological, Flow Cytometric, and Cytogenetic Assessments.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 3, p. 397, doi. 10.1038/ajg.2011.350
    By:
    • Yasuda, Ichiro;
    • Goto, Naoe;
    • Tsurumi, Hisashi;
    • Nakashima, Masanori;
    • Doi, Shinpei;
    • Iwashita, Takuji;
    • Kanemura, Nobuhiro;
    • Kasahara, Senji;
    • Adachi, Seiji;
    • Hara, Takeshi;
    • Shimizu, Masahito;
    • Takami, Tsuyoshi;
    • Moriwaki, Hisataka
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2005, v. 131, n. 2, p. 73, doi. 10.1007/s00432-004-0600-9
    By:
    • Goto, Hideko;
    • Tsurumi, Hisashi;
    • Takemura, Masao;
    • Ino-Shimomura, Yoriko;
    • Kasahara, Senji;
    • Sawada, Michio;
    • Yamada, Toshiki;
    • Hara, Takeshi;
    • Fukuno, Kenji;
    • Goto, Naoe;
    • Okuno, Masataka;
    • Takami, Tsuyoshi;
    • Seishima, Mitsuru;
    • Moriwaki, Hisataka
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 8, p. 1494, doi. 10.3109/10428194.2012.660627
    By:
    • Goto, Naoe;
    • Tsurumi, Hisashi;
    • Takemura, Masao;
    • Kanemura, Nobuhiro;
    • Kasahara, Senji;
    • Hara, Takeshi;
    • Yasuda, Ichiro;
    • Shimizu, Masahito;
    • Yamada, Toshiki;
    • Sawada, Michio;
    • Takahashi, Takeshi;
    • Yamada, Tetsuya;
    • Seishima, Mitsuru;
    • Moriwaki, Hisataka;
    • Takami, Tsuyoshi
    Publication type:
    Article
    50